Literature DB >> 32916044

Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients.

Christian Gampe1, Vishal A Verma1.   

Abstract

There is a dichotomy between the increasing utility of aldehydes as tool molecules that bind to "undruggable" protein sites and the designation of the aldehyde functional group as a structural alert by the medicinal chemistry community. Herein we compile information about pharmacologically active aldehydes that are being used in humans. We summarize the learnings from these data, discuss advantages and challenges associated with aldehydes, and derive strategies for the successful development of aldehydes within drug discovery programs.

Entities:  

Year:  2020        PMID: 32916044     DOI: 10.1021/acs.jmedchem.0c01177

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Reversible lysine-targeted probes reveal residence time-based kinase selectivity.

Authors:  Tangpo Yang; Adolfo Cuesta; Xiaobo Wan; Gregory B Craven; Brad Hirakawa; Penney Khamphavong; Jeffrey R May; John C Kath; John D Lapek; Sherry Niessen; Alma L Burlingame; Jordan D Carelli; Jack Taunton
Journal:  Nat Chem Biol       Date:  2022-05-19       Impact factor: 16.174

2.  Self-Masked Aldehyde Inhibitors of Human Cathepsin L Are Potent Anti-CoV-2 Agents.

Authors:  Jiyun Zhu; Linfeng Li; Aleksandra Drelich; Bala C Chenna; Drake M Mellott; Zane W Taylor; Vivian Tat; Christopher Z Garcia; Ardala Katzfuss; Chien-Te K Tseng; Thomas D Meek
Journal:  Front Chem       Date:  2022-07-04       Impact factor: 5.545

3.  Synthesis and Metabolism of BTN3A1 Ligands: Studies on Modifications of the Allylic Alcohol.

Authors:  Nicholas A Lentini; Chloe M Schroeder; Nyema M Harmon; Xueting Huang; Megan A Schladetsch; Benjamin J Foust; Michael M Poe; Chia-Hung Christine Hsiao; Andrew J Wiemer; David F Wiemer
Journal:  ACS Med Chem Lett       Date:  2020-12-04       Impact factor: 4.345

Review 4.  A Patent Review on SARS Coronavirus Main Protease (3CLpro ) Inhibitors.

Authors:  C S Brian Chia; Weijun Xu; Pearly Shuyi Ng
Journal:  ChemMedChem       Date:  2021-10-28       Impact factor: 3.540

5.  A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir.

Authors:  Subramanyam Vankadara; Monique Danielle Dawson; Jia Yi Fong; Qin Yao Oh; Qi An Ang; Boping Liu; Hong Yun Chang; Judice Koh; Xiaoying Koh; Qian Wen Tan; Joma Joy; Cheng San Brian Chia
Journal:  ACS Med Chem Lett       Date:  2022-07-19       Impact factor: 4.632

6.  A Neglected Challenge in the Analysis of Active Pharmaceutical Substances with Aldehyde Functional Group in Aqueous Matrices.

Authors:  Azadeh Nasiri; Shaya Mokhtari; Bahram Daraei; Hassan Yazdanpanah; Mehrdad Faizi; Farzad Kobarfard
Journal:  Iran J Pharm Res       Date:  2022-05-24       Impact factor: 1.962

7.  Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.

Authors:  Chamandi S Dampalla; Yunjeong Kim; Naemi Bickmeier; Athri D Rathnayake; Harry Nhat Nguyen; Jian Zheng; Maithri M Kashipathy; Matthew A Baird; Kevin P Battaile; Scott Lovell; Stanley Perlman; Kyeong-Ok Chang; William C Groutas
Journal:  J Med Chem       Date:  2021-07-02       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.